|
|
 |
 |
Search Results for: A |
 |
|
 |
|
|
 |
| 16 |
Atomoxetine hydrochloride
Manus Aktteva offers Atomoxetine hydrochloride, 82248-59-7,for your RND, Pilots and commercial requirements with supportive Drug master file
View Detail
| List of Intermediates
|
 |
|
|
| 17 |
Atorvastatin calcium
Manus Aktteva offers Atorvastatin calcium, amorphous, 134523-03-8, and also its intermediates, for your RND, Pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
| List of Intermediates
|
 |
|
|
| 18 |
Atosiban
Atosibanis an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labor. Although initial studies suggested it could be used as a nasal spray and hence would....
View Detail
| List of Intermediates
|
 |
|
|
| 19 |
Atovaquone
Manus Aktteva offers Atovaquone, 95233-18-4,for your RND, Pilots and commercial requirements with supportive Drug master file
View Detail
| List of Intermediates
|
 |
|
|
| 20 |
Atracurium besylate
Atracurium is a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarising neuromuscular-blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation ....
View Detail
| List of Intermediates
|
 |
|
|
| 21 |
Azacitidine
Manus Aktteva offers Azacitidine, 320-67-2, for your RND and Azacitidine Intermediates for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation
View Detail
| List of Intermediates
|
 |
|
|
| 22 |
(+)-(3aR,4R,5r,6aS)-Hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-4-(3-trifluoromethyl)phenoxy-1-butenyl]-2H-cyclopenta[b]furan-2-one
Manus Aktteva offers Travoprost Intermediate, 53872-60-9, (+)-(3aR,4R,5r,6aS)-Hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-4-(3-trifluoromethyl)phenoxy-1-butenyl]-2H-cyclopenta[b]furan-2-one, for your requirements of RND, evaluation, pilots and commercia....
View Detail
|
 |
|
|
| 23 |
(+)-(3aR,4R,5r,6aS)-Hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-2-one
Manus Aktteva offers Intermediate of Bimatoprost, having cas no 41639-74-1, for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermediates.
View Detail
|
 |
|
|
| 24 |
(3aR,4R,5R,6aS)-4-[(1E)-4-(3-Chlorophenoxy)-3-hydroxy-1-buten-1-yl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one
Manus Aktteva offers 652152-39-1, Cloprostenol Intermediates, including, (3aR,4R,5R,6aS)-4-[(1E)-4-(3-Chlorophenoxy)-3-hydroxy-1-buten-1-yl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one, with supportive technical package required for evaluation
View Detail
|
 |
|
|
| 25 |
(3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-(3-oxo-1-octen-1-yl)-2H-cyclopenta[b]furan-2-one
Manus Aktteva offers 185225-06-3, Intermediate for Dinoprostone, (3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-(3-oxo-1-octen-1-yl)-2H-cyclopenta[b]furan-2-one, with supportive technical package required for evaluation
View Detail
|
 |
|
|
| 26 |
(3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-2-one
Manus Aktteva offers 208111-98-2, Intermediate of Travoprost, (3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-2-one, for your requirements of RND, evaluation, pilots and commerc....
View Detail
|
 |
|
|
| 27 |
(3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-2-one
Manus Aktteva offers Intermediate of Latanoprost (3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-2-one, having cas no 55076-60-3 for your requirements of RND, evaluation, pilots and commercial along wi....
View Detail
|
 |
|
|
| 28 |
(7a,17a)-17-Hydroxy-3-oxo-pregna-4,9(11)-diene-7,21-dicarboxylicacid g-lactone methyl ester
Manus Aktteva offers Eplerenone intermediate, (7a,17a)-17-Hydroxy-3-oxo-pregna-4,9(11)-diene-7,21-dicarboxylicacid g-lactone methyl ester, 95716-70-4, for your evaluation, pilots and commercial requirements with supportive technical package required ....
View Detail
|
 |
|
|
| 29 |
(Alpha-meta hydroxy phenyl) ethyl dimethyl amine
Manus Aktteva offers Rivastigmine Intermediate, (Alpha-meta hydroxy phenyl) ethyl dimethyl amine, 105601-04-5, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 30 |
(Alpha-metahydroxyphenyl) ethyl dimethylamine hydrochloride
Manus Aktteva offers Rivastigmine Intermediate, (Alpha-meta hydroxy phenyl) ethyl dimethyl amine hydrochloride, 894079-56-2, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
|
|
|
|
|
 |
NOTE:
- Manus Aktteva, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Product enquiries may please be sent to info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|
|